Loading clinical trials...
Loading clinical trials...
Open Label Randomized Trial of Early Assessment of Therapy Response Using 18FDG-PET/CT in Patients With Marginally Resectable Stage IIIA (N2) Non-Small Cell Lung Cancer (NSCLC) Treated With Induction Concurrent Chemoradiation Followed by Resection and Adjuvant Chemotherapy
Conditions
Interventions
positron emission tomography/computed tomography (PET/CT)
fludeoxyglucose F 18
Start Date
April 1, 2011
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2012
Last Updated
June 29, 2012
NCT01629498
NCT02495896
NCT04062708
NCT01993810
NCT01737502
NCT03154190
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions